Neko Health, a startup co-founded by Daniel Ek that offers AI-based full-body scans, raised a $260M Series B led by Lightspeed, sources say at a $1.7B valuation
Tim Bradshaw / Financial Times :
Context & Ripple Effects
Neko Health moved from an AI-powered full-body scanner unveiled from stealth to a €60M funding round led by Lakestar in 2023. The reported Series B is a much larger financing step for the same consumer health-screening model.
The company had also launched in London as its first city outside Sweden, making capital availability especially consequential as it moves beyond its initial market.
First-order effects
- Neko Health gains reported access to $260M of growth capital at a $1.7B valuation, while Lightspeed becomes the reported lead backer of the Series B.
- The financing gives Neko greater capacity to support its full-body scan service as it operates across Sweden and London.
Second-order effects
- Neko’s larger balance sheet raises the competitive bar for other AI-enabled health-screening services seeking capital, customers, and expansion opportunities.
- Lightspeed’s reported lead role gives the company a strong investor signal as it pursues growth beyond its original market.
Third-order effects
- If similarly large rounds continue, AI-enabled preventive screening may become a more capital-intensive health-services category, favoring companies that can fund both technology and local service delivery.
- The pattern would shift competition from scanner development alone toward building repeatable, multi-market healthcare operations; the available coverage does not establish how quickly that model can scale.
The trend: This is one data point in the funding of AI-enabled preventive health services as startups pair software-driven screening with physical delivery networks.